跳至主要内容
临床试验/EUCTR2006-001125-26-GB
EUCTR2006-001125-26-GB进行中(未招募)1 期

A randomised controlled trial of oral l-arginine supplementation on platelet and endothelial function and walking distance in patients with peripheral arterial disease - L-ARGININE IN PAD

niversity of Aberdeen0 个研究点目标入组 56 人开始时间: 2006年7月23日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
56

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • All patients must be able to give informed consent, have an ABPI<0.8 and be on a statin and aspirin. If patients are not on these medications they will be commenced and enrolled 6 weeks later. We wish to determine the adjuvant effects of L-arginine in patients with PAD on what is considered to be routine medical therapy. All patients in this study will attend our nurse led claudication clinic and strict attention will be paid to secondary risk factor prevention as per our local guidelines.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Patients with rest pain or ulceration, liver impairment or abnormal platelet count or diabetes and those on clopidogrel, warfarin or non-steroidal anti-inflammatory drugs other than aspirin.

研究者

发起方
niversity of Aberdeen

相似试验

A randomised controlled trial of oral l-arginine... | 临床试验